{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52937"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52937","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"ADVANCING MASS SPECTROMETRY-BASED HUMAN PLASMA PROTEOMICS USING A NANOPARTICLE PROTEIN CORONA STRATEGY","abstract":"Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","abstract_html":"Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","abstract_has_math":false,"creators":["Sadeghi, SeyedAmirhossein"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Sun, Liangliang","Swain, Greg","Mahmoudi, Morteza","Qiu, Tian"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T18:59:34Z","subjects":["Analytical chemistry"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52937","local:Sadeghi_grad.msu_0128D_21945"],"render_values":[{"text":"etd:52937","href":null,"code":true},{"text":"local:Sadeghi_grad.msu_0128D_21945","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/p6nd-w536","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/p6nd-w536","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52937","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Sun, Liangliang","Swain, Greg","Mahmoudi, Morteza","Qiu, Tian"]},{"key":"dc:creator","label":"Author","values":["Sadeghi, SeyedAmirhossein"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Analytical chemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52937","local:Sadeghi_grad.msu_0128D_21945","https://doi.org/doi:10.25335/p6nd-w536"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","Proteomics seeks to comprehensively characterize the full complement of proteins present in biological systems; however, the extraordinary molecular complexity of proteomes, driven by post-translational modifications (PTMs), sequence variants, truncations, and higher-order assemblies, continues to challenge analytical methodologies. Mass spectrometry (MS)–based proteomics has emerged as the core technology for addressing these challenges. Bottom-up proteomics (BUP), which relies on enzymatic digestion and peptide-level analysis, enables deep proteome coverage but often suffers from limited sequence continuity and ambiguity in distinguishing distinct proteoforms. In contrast, top-down proteomics (TDP) directly analyzes intact proteins, preserving combinatorial PTMs and sequence variants, but remains analytically demanding due to constraints in separation efficiency, sensitivity, and long-term robustness. Consequently, continued advances in separation science, MS instrumentation, and integrative analytical strategies are required to fully realize proteoform-resolved proteomics.This dissertation focuses on the development, optimization, and application of advanced MS-based proteomics platforms that improve analytical reproducibility, separation performance, and proteoform-level characterization. Particular emphasis is placed on capillary zone electrophoresis coupled with tandem mass spectrometry (CZE–MS/MS), nanoparticle protein corona–based sample preparation, and the integration of BUP, TDP, and computational analysis. Across multiple biological systems, these approaches collectively enhance proteome depth, quantitative reliability, and confidence in proteoform annotation. In Chapter 2, the long-term qualitative and quantitative reproducibility of CZE–MS/MS for top-down proteomics was systematically investigated for the first time using a complex yeast cell lysate. More than 1,000 proteoforms were consistently identified per run across a total of 62 consecutive CZE–MS/MS analyses using a single linear polyacrylamide–coated separation capillary. Despite the overall robustness of the platform, substantial decreases in proteoform signal intensity and identification numbers were observed after repeated runs due to adsorption of proteoforms to the capillary inner wall. To address this limitation, a simple and effective capillary cleanup protocol based on diluted ammonium hydroxide was developed. Implementation of this protocol restored separation performance and enabled reproducible qualitative and quantitative proteoform measurements across at least 23 consecutive runs. These results demonstrate that CZE–MS/MS, when paired with appropriate operational control, is sufficiently robust for large-scale quantitative top-down proteomics of complex samples. This chapter is based on my published paper with PubMed identifier (PMID) of 38417052. Chapter 3 extends top-down proteomics to the characterization of nanoparticle protein coronas, a critical determinant of nanoparticle biological identity. A robust and reproducible TDP workflow was developed to directly analyze intact proteoforms adsorbed onto polystyrene nanoparticle surfaces. Application of this approach enabled the identification of approximately 900 distinct proteoforms spanning a mass range of roughly 2–70 kDa, including proteoforms derived from 48 known biomarker proteins. These proteoforms contained diverse combinations of PTMs, signal peptide cleavages, and truncations that could not be fully resolved using conventional BUP approaches. This work establishes TDP as a powerful analytical strategy for proteoform-level characterization of nanoparticle protein coronas and highlights its advantages over peptide-centric methodologies. This chapter is based on my published paper with PMID of 39276099. In Chapter 4, protein corona profiling was integrated with MS-based BUP, machine learning, and formal causality analysis to enable data-driven biomarker discovery in complex disease settings. Protein corona samples generated from 35 human plasma specimens across four clinical groups yielded a total of 887 unique proteins identified by BUP. Among these, 260 proteins were consistently observed across all samples and were enriched in pathways associated with atherosclerotic cardiovascular disease and prostate cancer. Statistical feature selection using least absolute shrinkage and selection operator (LASSO) regression reduced this set to 22 proteins strongly associated with disease state. Subsequent automated reasoning and causality analysis identified thromboxane-A synthase 1 (TBXAS1) as a primary causal factor and chaperonin containing TCP1 subunit 7 (CCT7) as a shared biomarker across disease conditions. This study demonstrates how large-scale proteomics data can be coupled with computational inference to extract mechanistically relevant information from complex datasets. This chapter is based on my published paper with PMID of 40190726. Chapter 5 advances proteoform-level characterization of nanoparticle protein coronas through large-scale integration of BUP and TDP datasets. Top-down analysis of polystyrene nanoparticle protein coronas from human plasma identified 3,505 proteoforms corresponding to 344 genes, representing nearly a fourfold increase in proteoform and gene identifications compared to previous studies. Complementary BUP analysis of the same samples yielded 4,570 protein groups, 45,790 peptides, and 23,632 modified peptides, constituting one of the most comprehensive plasma protein corona datasets reported to date. Joint interpretation of the TDP and BUP datasets enabled confident annotation of nearly 35% of proteoforms containing unexplained mass shifts, significantly improving PTM assignment and localization. This integrative strategy demonstrates the power of combining peptide- and proteoform-level information to generate a high-resolution molecular landscape of the protein corona. This chapter is based on my published paper with PMID of 41001529. Collectively, the studies presented in this dissertation advance MS-based proteomics across several analytical dimensions, including long-term platform reproducibility, high-efficiency separations, proteoform-resolved nanoparticle corona analysis, and integrative data interpretation supported by computational methods. By quantitatively demonstrating improvements in proteome depth, reproducibility, and annotation confidence, this work establishes a robust technical framework for proteoform-centric proteomics and provides broadly applicable methodologies for future investigations of complex proteomes.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (162 p.) : ill."]},{"key":"dc:title","label":"Title","values":["ADVANCING MASS SPECTROMETRY-BASED HUMAN PLASMA PROTEOMICS USING A NANOPARTICLE PROTEIN CORONA STRATEGY"]}]}],"canonical_facts":{"dc:contributor":["Sun, Liangliang","Swain, Greg","Mahmoudi, Morteza","Qiu, Tian"],"dc:creator":["Sadeghi, SeyedAmirhossein"],"dc:date":["2026"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","Proteomics seeks to comprehensively characterize the full complement of proteins present in biological systems; however, the extraordinary molecular complexity of proteomes, driven by post-translational modifications (PTMs), sequence variants, truncations, and higher-order assemblies, continues to challenge analytical methodologies. Mass spectrometry (MS)–based proteomics has emerged as the core technology for addressing these challenges. Bottom-up proteomics (BUP), which relies on enzymatic digestion and peptide-level analysis, enables deep proteome coverage but often suffers from limited sequence continuity and ambiguity in distinguishing distinct proteoforms. In contrast, top-down proteomics (TDP) directly analyzes intact proteins, preserving combinatorial PTMs and sequence variants, but remains analytically demanding due to constraints in separation efficiency, sensitivity, and long-term robustness. Consequently, continued advances in separation science, MS instrumentation, and integrative analytical strategies are required to fully realize proteoform-resolved proteomics.This dissertation focuses on the development, optimization, and application of advanced MS-based proteomics platforms that improve analytical reproducibility, separation performance, and proteoform-level characterization. Particular emphasis is placed on capillary zone electrophoresis coupled with tandem mass spectrometry (CZE–MS/MS), nanoparticle protein corona–based sample preparation, and the integration of BUP, TDP, and computational analysis. Across multiple biological systems, these approaches collectively enhance proteome depth, quantitative reliability, and confidence in proteoform annotation. In Chapter 2, the long-term qualitative and quantitative reproducibility of CZE–MS/MS for top-down proteomics was systematically investigated for the first time using a complex yeast cell lysate. More than 1,000 proteoforms were consistently identified per run across a total of 62 consecutive CZE–MS/MS analyses using a single linear polyacrylamide–coated separation capillary. Despite the overall robustness of the platform, substantial decreases in proteoform signal intensity and identification numbers were observed after repeated runs due to adsorption of proteoforms to the capillary inner wall. To address this limitation, a simple and effective capillary cleanup protocol based on diluted ammonium hydroxide was developed. Implementation of this protocol restored separation performance and enabled reproducible qualitative and quantitative proteoform measurements across at least 23 consecutive runs. These results demonstrate that CZE–MS/MS, when paired with appropriate operational control, is sufficiently robust for large-scale quantitative top-down proteomics of complex samples. This chapter is based on my published paper with PubMed identifier (PMID) of 38417052. Chapter 3 extends top-down proteomics to the characterization of nanoparticle protein coronas, a critical determinant of nanoparticle biological identity. A robust and reproducible TDP workflow was developed to directly analyze intact proteoforms adsorbed onto polystyrene nanoparticle surfaces. Application of this approach enabled the identification of approximately 900 distinct proteoforms spanning a mass range of roughly 2–70 kDa, including proteoforms derived from 48 known biomarker proteins. These proteoforms contained diverse combinations of PTMs, signal peptide cleavages, and truncations that could not be fully resolved using conventional BUP approaches. This work establishes TDP as a powerful analytical strategy for proteoform-level characterization of nanoparticle protein coronas and highlights its advantages over peptide-centric methodologies. This chapter is based on my published paper with PMID of 39276099. In Chapter 4, protein corona profiling was integrated with MS-based BUP, machine learning, and formal causality analysis to enable data-driven biomarker discovery in complex disease settings. Protein corona samples generated from 35 human plasma specimens across four clinical groups yielded a total of 887 unique proteins identified by BUP. Among these, 260 proteins were consistently observed across all samples and were enriched in pathways associated with atherosclerotic cardiovascular disease and prostate cancer. Statistical feature selection using least absolute shrinkage and selection operator (LASSO) regression reduced this set to 22 proteins strongly associated with disease state. Subsequent automated reasoning and causality analysis identified thromboxane-A synthase 1 (TBXAS1) as a primary causal factor and chaperonin containing TCP1 subunit 7 (CCT7) as a shared biomarker across disease conditions. This study demonstrates how large-scale proteomics data can be coupled with computational inference to extract mechanistically relevant information from complex datasets. This chapter is based on my published paper with PMID of 40190726. Chapter 5 advances proteoform-level characterization of nanoparticle protein coronas through large-scale integration of BUP and TDP datasets. Top-down analysis of polystyrene nanoparticle protein coronas from human plasma identified 3,505 proteoforms corresponding to 344 genes, representing nearly a fourfold increase in proteoform and gene identifications compared to previous studies. Complementary BUP analysis of the same samples yielded 4,570 protein groups, 45,790 peptides, and 23,632 modified peptides, constituting one of the most comprehensive plasma protein corona datasets reported to date. Joint interpretation of the TDP and BUP datasets enabled confident annotation of nearly 35% of proteoforms containing unexplained mass shifts, significantly improving PTM assignment and localization. This integrative strategy demonstrates the power of combining peptide- and proteoform-level information to generate a high-resolution molecular landscape of the protein corona. This chapter is based on my published paper with PMID of 41001529. Collectively, the studies presented in this dissertation advance MS-based proteomics across several analytical dimensions, including long-term platform reproducibility, high-efficiency separations, proteoform-resolved nanoparticle corona analysis, and integrative data interpretation supported by computational methods. By quantitatively demonstrating improvements in proteome depth, reproducibility, and annotation confidence, this work establishes a robust technical framework for proteoform-centric proteomics and provides broadly applicable methodologies for future investigations of complex proteomes.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (162 p.) : ill."],"dc:identifier":["etd:52937","local:Sadeghi_grad.msu_0128D_21945","https://doi.org/doi:10.25335/p6nd-w536"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Analytical chemistry"],"dc:title":["ADVANCING MASS SPECTROMETRY-BASED HUMAN PLASMA PROTEOMICS USING A NANOPARTICLE PROTEIN CORONA STRATEGY"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:34Z"}